Actively Recruiting
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
Led by China National Center for Cardiovascular Diseases · Updated on 2024-11-06
22000
Participants Needed
1
Research Sites
141 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.
CONDITIONS
Official Title
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older; male or female.
- History of documented atrial fibrillation.
- Able to provide written informed consent.
You will not qualify if you...
- Subjects with moderate or severe mitral stenosis or a mechanical heart valve.
- Subjects with previous or planned atrial fibrillation ablation.
- Subjects with previous or planned left atrial appendage closure.
- Subjects unable to cooperate with follow-up after assessment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China, 100027
Actively Recruiting
Research Team
Z
Zhe Zheng, MD, PhD
CONTACT
S
Shuo Yuan, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here